Ubs Group Ag Royalty Pharma PLC Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ubs Group Ag holds 1,352,476 shares of RPRX stock, worth $44.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,352,476

Previous 50,000 2604.95%

Holding current value

$44.5 Million

Previous $1.28 Million 3202.12%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$25.75 - $33.86 $9.09 Million - $12 Million	-353,046 Reduced 20.7%	1,352,476 $42.1 Million
Q4 2024 Feb 14, 2025	BUY	$24.28 - $28.39 $2.14 Million - $2.5 Million	88,037 Added 5.44%	1,705,522 $43.5 Million
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $8.52 Million - $9.73 Million	332,365 Added 25.86%	1,617,485 $45.8 Million
Q2 2024 Aug 13, 2024	BUY	$26.26 - $29.9 $15.4 Million - $17.5 Million	585,185 Added 83.61%	1,285,120 $33.9 Million
Q1 2024 May 13, 2024	SELL	$27.46 - $31.33 $4.59 Million - $5.23 Million	-167,060 Reduced 19.27%	699,935 $21.3 Million
Q4 2023 Feb 09, 2024	BUY	$26.21 - $29.22 $3.21 Million - $3.58 Million	122,555 Added 16.46%	866,995 $24.4 Million
Q3 2023 Nov 09, 2023	BUY	$26.26 - $31.38 $1.44 Million - $1.72 Million	54,697 Added 7.93%	744,440 $20.2 Million
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $5.56 Million - $6.87 Million	187,788 Added 37.41%	689,743 $21.2 Million
Q1 2023 May 12, 2023	SELL	$32.77 - $39.4 $7.64 Million - $9.19 Million	-233,230 Reduced 31.72%	501,955 $18.1 Million
Q4 2022 Feb 08, 2023	BUY	$39.17 - $44.04 $9.53 Million - $10.7 Million	243,324 Added 49.47%	735,185 $29.1 Million
Q3 2022 Nov 10, 2022	BUY	$39.88 - $44.65 $11.7 Million - $13.1 Million	294,062 Added 148.67%	491,861 $19.8 Million
Q2 2022 Aug 10, 2022	SELL	$37.53 - $44.22 $10.5 Million - $12.4 Million	-279,890 Reduced 58.59%	197,799 $8.32 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $995,649 - $1.13 Million	26,579 Added 5.89%	477,689 $18.6 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $5.63 Million - $6.8 Million	159,970 Added 54.95%	451,110 $18 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $13.7 Million - $16 Million	-378,404 Reduced 56.52%	291,140 $10.5 Million
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $8.97 Million - $10.5 Million	225,011 Added 50.62%	669,544 $27.4 Million
Q1 2021 May 12, 2021	BUY	$42.34 - $52.82 $9.38 Million - $11.7 Million	221,447 Added 99.27%	444,533 $19.4 Million
Q4 2020 Feb 11, 2021	BUY	$36.12 - $50.05 $6.12 Million - $8.49 Million	169,536 Added 316.59%	223,086 $11.2 Million
Q3 2020 Nov 12, 2020	BUY	$38.56 - $48.36 $1.72 Million - $2.16 Million	44,649 Added 501.62%	53,550 $2.25 Million
Q2 2020 Jul 31, 2020	BUY	$44.5 - $52.11 $396,094 - $463,831	8,901 New	8,901 $432,000

Others Institutions Holding RPRX

# of Institutions

484

Shares Held

283M

Call Options Held

2.51M

Put Options Held

941K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.4B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account